| Serial Number | 88900009 |
| Word Mark | ONCOGENUITY |
| Filing Date | Monday, May 4, 2020 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Thursday, October 3, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 8, 2023 |
| Goods and Services | Pharmaceutical and medicinal preparations for the treatment of cancer and oncological conditions; Pharmaceuticals, namely, drug delivery agents in the form of compounds that facilitate delivery of injectable pharmaceutical preparations and in the form of subcutaneous compounds that provide controlled release, and in the form of injectable pharmaceuticals, powders, tablets, capsules, pills, caplets, liquid drops, sachets, spray, ointment, cream, gel, lotion, patch, inhaler, granule, film, suspension, infusion and suppository, capsules, and tablets of peptide nucleic acids for the treatment of cancer and oncological conditions; Oncological preparations, namely, pharmaceutical preparations for the detection, prevention, and treatment of cancer; Pharmaceutical and medicinal preparations for the treatment of cancer, cell transplants and cell transplant rejection, organ transplants and organ transplant rejection, angiogenesis, bacterial infection, peripheral blood stem cell mobilization, lymphoma, tissue regeneration, tissue repair, leukemia, drug-induced anemia, retrovirus, viral infections, hematopoietic deficit resulting from chemotherapy or radiation therapy, elevation of white blood cells; Stem cells for medical purposes; Synthetic peptides for the treatment of cancer and oncological conditions; Biological tissue cultures for medical purposes; Therapeutic products, namely, antibodies, proteins and peptide therapeutics for treating cancer and oncological conditions; Vaccine preparations; Medical assays for testing of body fluids |
| Goods and Services | Pharmaceutical product development services; Pharmaceutical product evaluation services; Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development of pharmaceuticals for the treatment of cancer and oncological conditions; Research and development of vaccines and medicines; Technical research in the field of pharmaceutical studies; Development of computer platform technology, namely, development of cancer immunotherapy software platforms for manufacturing therapeutics; Consulting services for others in the field of design, planning, and implementation of clinical trials; Information technology platform as Service (PaaS) featuring computer software platforms for cancer diagnosis and analysis of cancer symptoms and cancer treatment, in the medical field; Electronic data storage; Providing a bioinformatics platform as a service (PAAS) featuring computer software platforms for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Scientific research and analysis for medical purposes in the field of cancer, oncology and clinical trials |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 15, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 15, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Oncogenuity, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10019 |
| Party Name | Oncogenuity, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10019 |
| Event Date | Event Description |
| Thursday, May 7, 2020 | NEW APPLICATION ENTERED |
| Friday, May 15, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, July 29, 2020 | ASSIGNED TO EXAMINER |
| Tuesday, August 4, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 4, 2020 | NON-FINAL ACTION E-MAILED |
| Tuesday, August 4, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 3, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, February 3, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 3, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, June 21, 2021 | ASSIGNED TO EXAMINER |
| Monday, July 26, 2021 | SUSPENSION LETTER WRITTEN |
| Monday, July 26, 2021 | LETTER OF SUSPENSION E-MAILED |
| Monday, July 26, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Friday, February 4, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, August 12, 2022 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Tuesday, March 28, 2023 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Thursday, July 6, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 8, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 8, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 3, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 2, 2024 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 2, 2024 | SOU EXTENSION 1 FILED |
| Wednesday, April 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 3, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 3, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 3, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, October 3, 2024 | SOU EXTENSION 2 FILED |